Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review

被引:0
作者
Morrison, Tessalyn [1 ]
Gottman, Moriah [2 ]
Do, Toan [3 ]
Rosenbaum, James T. [4 ,5 ]
Ghetie, Daniela [6 ,7 ]
Friedman, Marcia [6 ,7 ]
机构
[1] Univ Vermont, Med Ctr, Dept Med, Burlington, VT USA
[2] Oregon Hlth & Sci Univ OHSU, Sch Med, Portland, OR USA
[3] Univ Calif San Diego, Dept Allergy & Immunol, San Diego, CA USA
[4] Legacy Hlth Syst, Portland, OR USA
[5] Corvus Pharmaceut, Burlingame, CA USA
[6] Oregon Hlth & Sci Univ, Dept Med, Div Rheumatol, Portland, OR USA
[7] Alpine Immune Sci, Seattle, WA USA
关键词
immune system diseases; rheumatoid arthritis; scleritis; vasculitis; CLINICAL-FEATURES; POSTERIOR SCLERITIS; VISUAL OUTCOMES; EPISCLERITIS; EPIDEMIOLOGY; PREDICTORS; CENTERS;
D O I
10.3899/jrheum.2023-0788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Scleritis may be idiopathic or caused by trauma, infections, or an immune-mediated disease (IMD). Our study aimed to understand the relationship between scleritis and IMD, including presenting characteristics, serologies, and treatment course. Understanding these associations may allow clinicians to risk-stratify patients and predict their clinical and treatment course. Methods. We conducted a retrospective chart review of 341 patients with scleritis seen at a tertiary care center between January 1, 2005, and December 31, 2020. Demographics, scleritis characteristics, treatment response, recurrence, and serologic data were compared among patients with idiopathic and IMD-associated scleritis . Results. Among patients with scleritis seen, 145 patients (43%) had an associated IMD, most commonly rheumatoid arthritis (RA; 39%), vasculitis (21%), or inflammatory bowel disease (14%). In most cases, the IMD diagnosis predated the scleritis presentation (63%), though vasculitis cases were more likely to develop during or after scleritis episodes. There were no significant differences in demographics or treatment failures among patients with scleritis with and without associated IMDs. Patients with IMDs were more likely to have a recurrence of scleritis (62% vs 49%, P = 0.02). Conclusion. At our ophthalmology center, 43% of patients with scleritis had an associated IMD, and most patients with an IMD were symptomatic from this disease prior to scleritis presentation. RA was the most commonly associated condition and typically predated the scleritis, whereas vasculitis was more likely diagnosed during or after the scleritis episode. Scleritis among patients with IMD is more likely to recur compared to scleritis that is idiopathic.
引用
收藏
页码:825 / 830
页数:6
相关论文
共 32 条
  • [1] Pattern of Scleritis in an Egyptian Cohort
    Abd El Latif, Eiman
    Seleet, Mouamen M.
    El Hennawi, Hazem
    Rashed, Mohamed Abdulbadiea
    Elbarbary, Hossameldeen
    Sabry, Karim
    Ibrahim, Mohamed Abdelmonagy
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (06) : 890 - 896
  • [2] Ahn Seong Joon, 2010, Korean J Ophthalmol, V24, P331, DOI 10.3341/kjo.2010.24.6.331
  • [3] Evaluation of patients with scleritis for systemic disease
    Akpek, EK
    Thorne, JE
    Qazi, FA
    Do, DV
    Jabs, DA
    [J]. OPHTHALMOLOGY, 2004, 111 (03) : 501 - 506
  • [4] Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia
    Al Barqi, Mohammad
    Behrens, Ashley
    Alfawaz, Abdullah M.
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (06) : 1215 - 1219
  • [5] Systemic Disease Associations in a Cohort of Hispanic Patients with Scleritis
    Arruza, Cristina
    Figueroa, Guillermo A. Requejo
    Colon, Javier
    Marquez, Estefania Ramirez
    Puebla, Guillermo
    Ortega, Daniela
    Rodriguez, Mariella Pappaterra
    Fontanet, Jose Lopez
    Colon, Alexandra
    Rodriguez, Sofia C. Ayala
    Grana, Erick Rivera
    Marrero, Frances
    Baez, Emilio
    Santos, Carmen
    Oliver, Armando L.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [6] Combined Ophthalmology and Rheumatology Evaluation in Systemic Autoimmune Diseases with Ocular Involvement: A Third Level Reference Center in Mexico
    Baquero-Ospina, Pablo
    Paquentin-Jimenez, Rebeca
    Hubbe-Tena, Claudia
    Elena Concha-Del-Rio, Luz
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (05) : 989 - 995
  • [7] Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center
    Berchicci, Luigi
    Miserocchi, Elisabetta
    Di Nicola, Maura
    La Spina, Carlo
    Bandello, Francesco
    Modorati, Giulio
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 293 - 298
  • [8] Health system wide "big data" analysis of rheumatologic conditions and scleritis
    Berkenstock, Meghan K.
    Carey, Andrew R.
    [J]. BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [9] Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease
    Braithwaite, Tasanee
    Adderley, Nicola J.
    Subramanian, Anuradhaa
    Galloway, James
    Kempen, John H.
    Gokhale, Krishna
    Cope, Andrew P.
    Dick, Andrew D.
    Nirantharakumar, Krishnarajah
    Denniston, Alastair K.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (07) : 1267 - 1276
  • [10] Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era
    Caimmi, Cristian
    Crowson, Cynthia S.
    Smith, Wendy M.
    Matteson, Eric L.
    Makol, Ashima
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (05) : 595 - 603